High Serum Alpha-2-Macroglobulin Level in Patients with Osteonecrosis of the Femoral Head

Document Type : RESEARCH PAPER


1 Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Department of Medical Genetics, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Orthopedic Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Medical Genetics, Mashhad University of Medical Sciences, Mashhad, Iran


Background: Diagnosis of osteonecrosis of the femoral head (ONFH) is complicated due to the lack of reliable serum biomarkers. Up-regulation of alpha-2-macroglobulin (A2M) gene has been reported in glucocorticoid-induced ANFH rat model. This study aimed to investigate whether the serum level of alpha-2-macroglobulin (A2M) can be used for ONFH diagnosis.
Methods: Serum protein capillary electrophoresis was performed on the sera of 36 ONFH patients. Also, human enzyme-linked immunosorbent assay was performed to evaluate the serum levels of A2M.
Results: Alpha-2 subunit level, composed of alpha-2-macroglobulin, ceruloplasmin and 2-2 haptoglobin phenotype, was increased significantly as compared to healthy subjects (P=0.0001). Moreover, ELISA assay confirmed significant elevation in the A2M (P=0.037).
Conclusion: Our findings suggest that avascular necrotic femur head presumably directly or indirectly elevates A2M in the bloodstream. Thus, serum level of A2M might be used as a reliable diagnostic tool in clinical practice.
Level of evidence: II


Main Subjects

1. Pouya F, Kerachian MA. Avascular necrosis of the
femoral head: are any genes involved? Arch Bone Jt
Surg. 2015; 3(3):149-55.
2. Mazloumi SM, Ebrahimzadeh MH, Kachooei AR.
Evolution in diagnosis and treatment of Legg-Calve-
Perthes disease. Arch Bone Jt Surg. 2014; 2(2):86-92.
3. Doheny R. Avascular necrosis of femoral head. New
York: Surgical Technologist; 2006.
4. Bose VC, Baruah BD. Resurfacing arthroplasty of
the hip for avascular necrosis of the femoral head: a
minimum follow-up of four years. J Bone Joint Surg Br.
2010; 92(7):922-8.
5. Kelly DM. Congenital and developmental anomalies
of the hip and pelvis. In: Canale ST, Beaty JH,
editors. Campbell’s operative orthopaedics. 12th ed.
Philadelphia: Elsevier-Mosby; 2013. P. 1079-118.
6. Candinas R, Jakob M, Buckingham TA, Mattmann
H, Amann FW. Vibration, acceleration, gravitation,
and movement: activity controlled rate adaptive
pacing during treadmill exercise testing and daily
life activities. Pacing Clin Electrophysiol. 1997;
7. Bejar J, Peled E, Boss JH. Vasculature deprivation--
induced osteonecrosis of the rat femoral head as a
model for therapeutic trials. Theor Biol Med Model.
2005; 2(5):24.
8. Chen WM. Osteonecrosis of the femoral head: surgical
perspective. Formosan J Surg. 2011; 44(4):131-5.
9. Ali YM, Sarwar JM, Sarker MC, Hossain MS, Kayes
MN, Rahman MM, et al. Core decompression by laser
osteoperforation: a preliminary report of new and
minimally invasive modality for the treatment of
avascular necrosis of the femoral head. Malaysian J
Med Biol Res. 2014; 1(1):9-17.
10. Hadjigeorgiou G, Dardiotis E, Dardioti M, Karantanas
A, Dimitroulias A, Malizos K. Genetic association
studies in osteonecrosis of the femoral head: mini
review of the literature. Skeletal Radiol. 2008;
11. Taheriazam A, Saeidinia A. Conversion of failed
hemiarthroplasty to total hip arthroplasty: a shortterm
follow-up study. Medicine. 2017; 96(40):e8235.
12. Strimbu K, Tavel JA. What are biomarkers? Curr Opin
HIV AIDS. 2010; 5(6):463-6.
13. Kerachian MA, Seguin C, Harvey EJ. Glucocorticoids
in osteonecrosis of the femoral head: a new
understanding of the mechanisms of action. J Steroid
Biochem Mol Biol. 2009; 114(3-5):121-8.
14. Kerachian MA, Cournoyer D, Harvey EJ, Chow TY,
Begin LR, Nahal A, et al. New insights into the
pathogenesis of glucocorticoid-induced avascular
necrosis: microarray analysis of gene expression in a
rat model. Arthritis Res Ther. 2010; 12(3):R124.
15. Lafforgue P. Pathophysiology and natural history of
avascular necrosis of bone. Joint Bone Spine. 2006;
16. Carli AV, Harvey EJ, Azeddine B, Gao C, Li Y, Li A, et
al. Substrain-specific differences in bone parameters,
alpha-2-macroglobulin circulating levels, and
osteonecrosis incidence in a rat model. J Orthop Res.
2017; 35(6):1183-94.
17. Ramadori G, Knittel T, Schwogler S, Bieber F, Rieder
H, Meyer zum Buschenfelde KH. Dexamethasone
modulates alpha 2-macroglobulin and apolipoprotein
E gene expression in cultured rat liver fat-storing (Ito)
cells. Hepatology. 1991; 14(5):875-82.
18. Milosavljevic TS, Petrovic MV, Cvetkovic ID, Grigorov
II. DNA binding activity of C/EBPbeta and C/EBPdelta
for the rat alpha2-macroglobulin gene promoter
is regulated in an acute-phase dependent manner.
Biochemistry. 2002; 67(8):918-26.
19. Soyfoo MS, Watik A, Stordeur P, Gangji V. Cryofibrinogen
levels are increased in non-traumatic osteonecrosis: a
new pathogenic clue to osteonecrosis? Rheumatology
(Oxford). 2013; 52(9):1694-700.
20. Amdo TD, Welker JA. An approach to the diagnosis
and treatment of cryofibrinogenemia. Am J Med.
2004; 116(5):332-7.
21. Chen Y, Zeng C, Zeng H, Zhang R, Ye Z, Xing B, et al.
Comparative serum proteome expression of the
steroid-induced femoral head osteonecrosis in adults.
Exp Ther Med. 2015; 9(1):77-83.
22. Wu RW, Wang FS, Ko JY, Wang CJ, Wu SL. Comparative
serum proteome expression of osteonecrosis of the
femoral head in adults. Bone. 2008; 43(3):561-6.
23. Pineiro M, Alava MA, Gonzalez-Ramon N, Osada J,
Lasierra P, Larrad L, et al. ITIH4 serum concentration
increases during acute-phase processes in human
patients and is up-regulated by interleukin-6 in
hepatocarcinoma HepG2 cells. Biochem Biophys Res
Commun. 1999; 263(1):224-9.
24. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U,
Schlegel P, Witt I, et al. Interleukin-6 and alpha-
2-macroglobulin indicate an acute-phase state
in Alzheimer’s disease cortices. FEBS Lett. 1991;